terrestrial

1 known investors

Terrestrial develops the Tacterra microarray patch platform to deliver a wide range of therapies, including GLP-1, through the skin using dissolvable tips—eliminating needles and refrigeration requirements. The platform enables patients to self-administer treatments at home or while traveling.

BiotechDigital HealthMedical Devices